In case you missed it: April 25 to April 29
A look back at the week's news.
This week's top headlines:
FDA warn public of risks, false results with noninvasive prenatal screening tests
The FDA recently issued a statement warning the public of the risks and potential false results obtained with noninvasive prenatal screening tests, noting that inappropriate usage and interpretation has resulted in improper medical decisions.
Coronavirus Omicron variant, vaccine, and case numbers in the United States: April 28, 2022
Omicron by the numbers.
Women’s health in review: April 2022
A look back at this month’s most popular stories, according to you.
Rotating shift work and onset of menopause
A Canadian study in Menopause suggests shift work may increase women's likelihood to experience delayed onset of menopause.
Prescription spending rose 12% in 2021
A report that tracks the use of medicines in the United States shows that spending on prescriptions rose 12% in 2021 primarily due to COVID-19 vaccines and therapies.
A legacy of excellence: Reflecting on the final print edition of Contemporary OB/GYN
April 25th 2025Marking the end of an era and the beginning of a new chapter, the final print edition of Contemporary OB/GYN celebrates over 50 years of evidence-based guidance and unwavering support for clinicians.
Read More
